Roche buys U.S. gene sequencing tech company Stratos Genomics
Fri May 22 2020
Lucy Harlow (3316 articles)

Roche buys U.S. gene sequencing tech company Stratos Genomics

General view of the Roche building in Welwyn Garden City, following the outbreak of the coronavirus disease (COVID-19), Welwyn Garden City, Britain, May 14, 2020. REUTERS/Paul Childs

Pharmaceutical group Roche (ROG.S) has acquired U.S.-based Stratos Genomics to further develop DNA-based sequencing for diagnostic use, it said on Friday.

“The acquisition provides Roche access to Stratos Genomics unique chemistry, Sequencing by Expansion,” the Swiss drug maker said in a statement. “The Roche nanopore sequencer, once developed, will utilise a novel approach that combines electronic and biological components to sequence DNA for fast, flexible and cost-effective clinical diagnostic testing.”

Financial details of the agreement were not disclosed.

Lucy Harlow

Lucy Harlow

Lucy Harlow is a senior Correspondent who has been reporting about Commodities, Currencies, Bonds etc across the globe for last 10 years. She reports from New York and tracks daily movement of various indices across the Globe

Discussion

Rules of Discussion on Live Index

1. This forum is for discussion of financial markets. Please respect others view even if they are contrary to you.
2. Member's comments should lead to value addition in forum discussion.
3. If anyone is found making repetitive Explicit/Abusive/Racial comments, his account shall be banned and old posts will be deleted.